@article{2da419206fd14f58bb10b439ef32497b,
title = "A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis",
abstract = "Cytokine and cytokine receptor genes, including IL2RA, IL7R and IL12A, are known risk factors for multiple sclerosis (MS). Excitotoxic oligodendroglial death mediated by glutamate receptors contributes to demyelinating reactions. In the present study, we screened 368 single-nucleotide polymorphisms (SNPs) in 55 genes or gene clusters coding for cytokines, cytokine receptors, suppressors of cytokine signaling (SOCS), complement factors and glutamate receptors for association with MS in a Spanish-Basque resident population. Top-scoring SNPs were found within or nearby the genes coding for SOCS-1 (P=0.0005), interleukin-28 receptor, alpha chain (P=0.0008), oncostatin M receptor (P=0.002) and interleukin-22 receptor, alpha 2 (IL22RA2; P=0.003). The SOCS1 rs243324 variant was validated as risk factor for MS in a separate cohort of 3919 MS patients and 4003 controls (combined Cochran-Mantel-Haenszel P=0.00006; odds ratio (OR)=1.13; 95\% confidence interval (CI)=1.07-1.20). In addition, the T allele of rs243324 was consistently increased in relapsing-remitting/secondary progressive versus primary-progressive MS patients, in each of the six data sets used in this study (P CMH 0.0096; OR1.24; 95\% CI 1.05-1.46). The association with SOCS1 appears independent from the chr16MS risk locus CLEC16A.",
keywords = "cytokine, genetics, multiple sclerosis, single-nucleotide polymorphismx, SOCS1",
author = "K. Vandenbroeck and J. Alvarez and B. Swaminathan and I. Alloza and F. Matesanz and E. Urcelay and M. Comabella and A. Alcina and M. Fedetz and Ortiz, \{M. A.\} and G. Izquierdo and O. Fernandez and N. Rodriguez-Ezpeleta and C. Matute and S. Caillier and R. Arroyo and X. Montalban and Oksenberg, \{J. R.\} and A. Antig{\"u}edad and A. Aransay",
note = "Funding Information: We express our gratitude to all patients and control subjects participating in this study. We thank the Basque Biobank of the Basque Foundation for Health Innovation and Research for supplying DNA samples. This study was supported by grants to K Vandenbroeck from the European Community{\textquoteright}s Seventh Framework Program (FP7/2007-2013) under grant agreement no 212877 (UEPHA*MS; www.reem.es/uepha-ms/), and from the Gobierno Vasco (Ref. IT512-10; Convocatoria {\textquoteleft}Grupos de Investigaci{\'o}n 2010–2015{\textquoteright}); by grants to A Aransay from the Gobierno Vasco (Ref. MV-2005-1-13; {\textquoteleft}Convocatoria de Programas de Perfeccionamiento y Movilidad del Personal Investigador 2005{\textquoteright}), the Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2005–2006) and from the Innovation Technology Department of the Bizkaia County; by project grant FIS PI10/1985 to E Urcelay; by grants to A Alcina from the Fondos Europeos de Desarrollo Regional (FEDER), Ministerio de Ciencia e Innovaci{\'o}n (SAF2009-11491) and Junta de Andaluc{\'i}a (P07-CVI-02551); and by grant FIS PI/081636 to F Matesanz.",
year = "2012",
month = jan,
doi = "10.1038/gene.2011.44",
language = "English",
volume = "13",
pages = "21--28",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "Springer Nature",
number = "1",
}